Disease Library/Obesity due to pro-opiomelanocortin deficiency/Advocacy Hub

Obesity due to pro-opiomelanocortin deficiency

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database
💊
1FDA treatments
🩺
1Specialists
💰
1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Obesity due to pro-opiomelanocortin deficiency.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

IMCIVREE

Rhythm Pharmaceuticals, Inc

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

IMCIVREE

(SETMELANOTIDE)standard

Rhythm Pharmaceuticals, Inc

Melanocortin 4 Receptor Agonist [EPC]

12.1 Mechanism of Action Setmelanotide is an MC4 receptor agonist with 20-fold less activity at the melanocortin 3 (MC3) and melanocortin 1 (MC1) rece...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Obesity due to pro-opiomelanocortin deficiency.
Search all trials →
Search clinical trials for Obesity due to pro-opiomelanocortin deficiency →

Recent News & Research

No recent news articles indexed yet for Obesity due to pro-opiomelanocortin deficiency.
Search PubMed for Obesity due to pro-opiomelanocortin deficiency →

Browse all Obesity due to pro-opiomelanocortin deficiency news →

Specialist Network

Top 1 by expertise
MS

Murray Stewart

Rhythm Pharmceuticals, Inc

Score 01 trial

View all Obesity due to pro-opiomelanocortin deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰

Latest News

Research, approvals & updates

📚

Browse All Diseases

11,000+ rare disease profiles